On April 29th, IHU SEPSIS had the distinct pleasure of welcoming the members of the International Scientific Advisory Board (iSAB) to Paris, in the magnificent setting of the Salons de l'Aéro-Club de France.
Innovation serving patients
Innovation serving patients
From diagnosis to treatment
By combining fundamental research, clinical trials, and cutting-edge technologies, we work every day to transform sepsis care.
What is
sepsis?
A public health priority
According to the WHO, sepsis affects around 50 million people worldwide each year (including 20 million children under the age of five) and causes nearly 11 million deaths, accounting for almost one-fifth of global mortality.
Sepsis
Stories
Sepsis
Stories
Discover the history of sepsis since the 18th century, when some physicians began questioning the contagious nature of the disease, and explore the theories and discoveries that have shaped sepsis management up to the present day.
The latest News from the IHU
On April 28th, IHU SEPSIS, in collaboration with OI MICROBES, hosted a PhD & Postdoctoral Research Day at the Paris-Saclay Faculty of Medicine in Le Kremlin-Bicêtre. Around thirty PhD students, postdoctoral fellows, and interns from various disciplines gathered to share ideas and present their work related to microbial sciences and sepsis.
The postdoctoral researcher will work in Unit 1176, Hemostasis Inflammation Thrombosis (HITh), INSERM/University Paris-Saclay, Le Kremlin-Bicêtre, France, in the group led by Delphine Borgel. This group focuses on the role of protein S in the regulation of thrombo-inflammation and immunothrombosis and is part of the IHU SEPSIS (Comprehensive Sepsis Center).
The latest recommendations from the Surviving Sepsis Campaign for adults and children were published on March 23, 2026, in the journal Intensive Care Medicine.
